Table 1.
Cpd | R | R′ | R″ | Inhibition of cell growth | Inhibition against Stat3 signaling | |||||
---|---|---|---|---|---|---|---|---|---|---|
U251MG | MDA-MB-231 | SF295 | NIH 3T3 | pYStat3 (cellular) | DNA binding activity (cellular) | Stat3/DNA complexation (cell-free) | ||||
6 | H | +++ | +++ | ++ | +++ | +++ | +++ | ++ | ||
7 | H | ++ | + | +/− | + | ++ | nd | ++ | ||
8 | H | H | +/− | +/− | +/− | − | − | nd | − | |
9 | CH3 | +/− | − | − | − | − | − | − | ||
10 | CH3 | ++ | + | − | +/− | ++ | +++ | + | ||
11 | H | H | +/− | +/− | − | − | − | + | +++ | |
14 | H | H | H | − | − | +/− | − | − | nd | − |
15 | CH3 | H | H | +/− | +/− | − | − | nd | nd | nd |
17 | CH3 | H | +/− | − | +/− | − | nd | nd | nd | |
18 | H | H | +/− | − | − | − | − | nd | − | |
19 | H | H | +/− | − | − | − | − | nd | − | |
20 | H | ++ | +/− | +/− | +/− | ++ | nd | +++ | ||
21 | H | H | − | − | − | − | − | nd | − | |
22 | H | H | ++ | +/− | +/− | +/− | +++ | +++ | +++ | |
28 | CH3 | H | +/− | − | +/− | − | − | nd | − |
Bold, most active agents; nd, not determined; +++ strongly active; ++ very active; + active; +/− moderately active or less active; − no activity; activities are measured at 5 μM; cpd, compound